• No results found

Adoptive immunotherapy after HLA mismatched stem cell transplantation Oosten, L.E.M.

N/A
N/A
Protected

Academic year: 2021

Share "Adoptive immunotherapy after HLA mismatched stem cell transplantation Oosten, L.E.M."

Copied!
2
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

Adoptive immunotherapy after HLA mismatched stem cell

transplantation

Oosten, L.E.M.

Citation

Oosten, L. E. M. (2007, November 21). Adoptive immunotherapy after HLA

mismatched stem cell transplantation. Retrieved from

https://hdl.handle.net/1887/12446

Version: Corrected Publisher’s Version

License: Licence agreement concerning inclusion of doctoral

thesis in the Institutional Repository of the University

of Leiden

Downloaded from: https://hdl.handle.net/1887/12446

Note: To cite this publication please use the final published version (if

applicable).

(2)

139

Abbreviations

aAPC artifi cial antigen-presenting construct

ALL acute lymphatic leukemia AML acute myeloid leukemia APC antigen-presenting cell APhC allophycocyanin APL altered peptide ligand

CDR complementarity-determining region

CLL chronic lymphatic leukemia CML chronic myeloid leukemia CMV cytomegalovirus

CTL cytotoxic T lymphocytes DC dendritic cell

DLI donor lymphocyte infusion EBV-LCL Epstein-Barr virus-transformed

lymphoblastoid cell lines E:T effector to target ratio ER endoplasmatic reticulum FACS fl uorescence-activated cell

sorter

FITC fl ourescein isothiocyanate GFP green fl uorescent protein GMP good manufacturing practices GvHD graft-versus-host disease GvL graft-versus-leukemia HLA human leukocyte antigens HPLC high performance liquid

chromatography HS human serum IFN- interferon- IL- interleukin-

IMDM Iscove’s modifi ed Dulbecco’s medium

mAb monoclonal antibody MFI mean fl uorescence intensity mHag minor histocompatibility

antigen

MHC major histocompatibility complex

MDS myelodysplastic syndrome MM multiple myeloma NK natural killer

PBMC peripheral blood mononuclear cell

PBS phosphate-buffered saline PCR polymerase chain reaction PE phycoerythrin

PerCP peridinin chlorophyll protein PR-3 proteinase-3

SCT stem cell transplantation TAP transporter associated with

antigen-processing TCR T cell receptor Th T helper

TNF- tumor necrosis factor- UCB umbilical cord blood WT1 Wilms’ tumor antigen

Referenties

GERELATEERDE DOCUMENTEN

The kinetics of IFNγ production were similar for peptide concentrations below 10 -7 M with maximal IFNγ production after 4 hours of stimulation, however, the

To further extend the repertoire of CMV-specific T cells that could be activated in peripheral blood from CMV seropositive donors for IFNγ-based isolation, we next

The relation between the development of hexon-specific T cells and control of HAdV infection was illustrated by the minor HAdV reactivation at day 152 after transplantation in

Interestingly, one of the isolated T cell clones bound all HLA-A2 tetramers tested with high intensity but showed no lytic activity to HLA-A2 pos target cells whatsoever..

In theory, alloHLA-restricted mHag-specifi c cytotoxic T cells should lyse the patient’s hematopoietic cells, including leukemic cells, but not non-hematopoietic cells that do

Het bloedcel-specifi eke peptide komt wel tot expressie op de bloedcellen van de patiënt (want die hebben het juiste HLA-molecuul), maar niet op de bloedcellen van de donor (die

Het onderzoek gepresenteerd in dit proefschrift werd verricht van 2000 tot 2005 op de afdeling Immunohematologie en Bloedtransfusie van het Leids Universitair Medisch Centrum

Het gemak waarmee wordt aangenomen dat vrouwen met een niet-europese achtergrond niet weten wat goed voor hen is, geeft aan dat ook in Europa de vrouwenemancipatie nog lang niet